Piper Sandler Rates Synopsys (SNPS) buy, $550 Price Target

Piper Sandler raised its price target for Synopsys, Inc. to $550, maintaining a 'buy' rating, a 18.55% upside from the current price.

Reviewed by automated data checks against the source data. How we make and check alerts

Piper Sandler rated Synopsys, Inc. ($SNPS) "buy" with a $550 price target on June 23, 2026.

Since the rating, $SNPS is down 3.3% after 1 week, down 19.1% after 1 month and down 1.5% to date (from the $461.50 close on Jun 23, 2026).

SNPS Synopsys, Inc.
$454.63 -5.37% year to date
Daily close · Oct 16, 2026

Key Points

  • Piper Sandler's analyst Clarke Jeffries upgraded Synopsys to 'buy' with a new price target of $550 on June 23, 2026.
  • Piper Sandler's $550 price target implies 18.55% upside from Synopsys, Inc.'s ($SNPS) current $463.93 share price.
  • Synopsys shares traded at $464.58 on Tuesday, with a market cap of about $88.96 billion and a forward P/E of 26.9.
  • Major institutional investors like BlackRock and Vanguard have been adjusting their holdings in Synopsys recently.

Get $SNPS trade alerts by text

We text you when insiders, Congress or big funds trade $SNPS. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Synopsys, Inc. alert may contain errors. Disclosures

Piper Sandler has upgraded Synopsys, Inc. (NasdaqGS: SNPS) to a 'buy' rating, setting a new price target of $550. This change was announced on June 23, 2026, by analyst Clarke Jeffries. On the same day, Synopsys shares traded at approximately $464.58.

Analyst rating track record

Piper Sandler vs. the S&P 500

YTD return -14.98% hypothetical
All-time return +27.16% S&P 500 +36.09%
vs. S&P 500 -8.93% behind the index

Hypothetical returns from Piper Sandler's disclosed trades, not real profit or advice. How we model this.

Analysts Set New Price Targets

On June 23, 2026, Piper Sandler's Clarke Jeffries upgraded Synopsys to a 'buy' rating with a new price target of $550. Previously, Citigroup maintained a 'buy' rating with a $610 target on May 28, 2026. Other firms like BNP Paribas and Stifel also provided ratings, with BNP maintaining a 'sell' at $450 and Stifel a 'buy' at $600.

Synopsys, Inc. Stock Down 3.3%

Shares of Synopsys traded near $464.58 on Tuesday. The company, with a market cap of about $88.96 billion, has a forward P/E ratio of 26.9 and a beta of 1.214. Over the past 52 weeks, the stock has ranged from $376.18 to $651.73. It has a 50-day moving average of $479.26 and a 200-day moving average of $459.47.

12-month forecast

$SNPS price target

Synopsys, Inc. daily closes and this analyst's $550 target. Not advice.

Insider Buying and Selling at Synopsys, Inc.

On June 15, 2026, several insiders at Synopsys made trades. Deputy CFO & CAO Sudhindra Kankanwadi bought 720 shares and sold 249 shares at an average price of $454.38. Meanwhile, President and CEO Sassine Ghazi sold 14,603 shares, and Chief Revenue Officer Michael Ellow sold 2,543 shares at the same average price.

Other Institutional Activity in Synopsys

BlackRock, Inc. increased its holdings in Synopsys by 725,174 shares, ending with 15,865,780 shares valued at about $6.29 billion. Vanguard Capital Management LLC opened a new position with 12,442,898 shares worth approximately $4.93 billion. State Street Corp added 110,133 shares, reaching a total of 8,899,023 shares valued at $3.53 billion. FMR LLC boosted its stake by 873,487 shares to hold 8,365,655 shares worth around $3.32 billion.

About Synopsys

Synopsys, Inc., based in Sunnyvale, California, is a leader in the technology sector, specifically in software infrastructure. The company provides a range of design IP solutions for the semiconductor and electronics industries. It operates through two main segments: Design Automation and Design IP. Synopsys is known for its digital and custom IC design solutions, verification solutions, and AI-driven EDA solutions. Under the leadership of CEO Sassine Ghazi, Synopsys employs around 28,000 people.

Bottom Line

Piper Sandler's upgrade of Synopsys to a 'buy' with a $550 price target reflects confidence in the company's future prospects. Synopsys continues to be a significant player in the technology sector, with major institutional investors actively adjusting their positions. As always, it's important to remember that analyst ratings and 13F filings are backward-looking and may not reflect current conditions.

Source: Piper Sandler's rating change on $SNPS (Jun 23, 2026). Written by software, not financial advice. How we make alerts

Get $SNPS trade alerts by text